GGrantIndex
Sort

326,823 grants matching clinical trial

Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ

$4,343,297
Georgia D Tomaras · Duke University · P01 · FY2021 · AI

The CRISPR Vision Program: Nonviral Genome Editing Platforms to Treat Inherited Retinal Channelopathies

$4,343,177
Krishanu Saha · University Of Wisconsin-Madison · U19 · FY2025 · NS

Boston HIV CTU

$4,338,234
Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2023 · AI

Center for AIDS Research

$4,338,043
David Mitchell Smith · University Of California, San Diego · P30 · FY2020 · AI

COG NCTN Network Group Operations Center

$4,337,479
Douglas S. Hawkins · Public Health Institute · U10 · FY2021 · CA

Leadership Center Administration

$4,337,276
Robert A Wood · Johns Hopkins University · UM2 · FY2017 · AI

IND-enabling program for a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder

$4,336,347
Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2023 · DA

The VITamin D and OmegA-3 TriaL (VITAL)

$4,335,161
Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2015 · CA

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success

$4,334,033
Barry Coller · Rockefeller University · UL1 · FY2018 · TR

DCTD Cancer Imaging

$4,331,419
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA

IMPACTA PERU CLINICAL TRIALS UNIT

$4,328,745
Javier R Lama · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2020 · AI

MIS-C Program: Data Coordinating Center for the Pediatric Heart Network MIS-C Program

$4,327,649
Julie Elaine Miller · New England Research Institutes, Inc. · U24 · FY2020 · HL

The Alzheimer's Disease Research Center at the University of California, Irvine

$4,325,343
Frank M Laferla · University Of California-Irvine · P30 · FY2025 · AG

Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 hospitalized pa

$4,325,153
Marla J Keller · Albert Einstein College Of Medicine · UL1 · FY2020 · TR

INFRASTRUCTURE: HMO CANCER RESEARCH NETWORK

$4,323,694
Edward H Wagner · Kaiser Foundation Health Plan Of Washington · U19 · FY2010 · CA

Training and Development of Outstanding Surgeon Scientists

$4,323,501
Martha Zeiger · Division Of Basic Sciences - Nci · ZIE · FY2021 · CA

Biodefense and Emerging Infectious Disease and Influenza Vaccine Studies

$4,323,375
Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

HPTN - CENTRAL LABORATORY

$4,322,963
Johns Hopkins University · U01 · FY2002 · AI

Data, Modeling,and Coordination Center for PrecISE Network

$4,322,714
Anastasia Ivanova · Univ Of North Carolina Chapel Hill · U24 · FY2022 · HL

Data Management Core

$4,320,496
Wendy Bergantz · University Of Chicago · U10 · FY2020 · CA

Pathogenic Mechanisms in Spondyloarthritis

$4,318,760
Robert Colbert · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR

Technical, Data and Health Care Systems Core (TDHCS) (B)

$4,318,310
Daniella Meeker · Brown University · U54 · FY2025 · AG

AIDS and Cancer Specimen Resource (ACSR)

$4,317,263
Sylvia Silver · George Washington University · UM1 · FY2020 · CA

Genetic Basis Of Cortical Malfunction In Schizophrenia

$4,316,676
Daniel Weinberger · National Institute Of Mental Health · ZIA · FY2010 · MH

Data Management Core

$4,315,959
Sumithra Jay Mandrekar · Mayo Clinic Rochester · U10 · FY2021 · CA